Replies to post #17468 on Aurinia Pharmaceuticals Inc (AUPH)

[rosemountbomber]

On the same track as what you are talking about, IIRC Aurinia’s margin on Lupkynis is astronomical so they would have room to decrease the price. I have thought that they didn’t want to decrease margins so as to appear more attractive to BP wrt a BO.

But a number of years have passed since approval and management has not been able to get more favorable insurance coverage nor has Aurinia been able to attract a suitor.

[rosemountbomber]

Meant to add this link from ICER:

https://icer.org/wp-content/uploads/2020/11/LN_RAAG.pdf